![Dámaso Molero](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dámaso Molero
Algemeen Directeur bij 3P Biopharmaceuticals SL
Actieve functies van Dámaso Molero
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Algemeen Directeur | 01-04-2007 | - |
President | 16-12-2009 | 30-01-2014 |
Loopbaan van Dámaso Molero
Eerdere bekende functies van Dámaso Molero
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHIONOGI & CO., LTD. | Corporate Officer/Principal | - | - |
ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
Syntex, Inc. | Corporate Officer/Principal | - | - |
Glaxo, Inc. | Corporate Officer/Principal | - | - |
Opleiding van Dámaso Molero
University of Navarra | Masters Business Admin |
Statistieken
Internationaal
Spanje | 3 |
Canada | 3 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Executive Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
SHIONOGI & CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
3P Biopharmaceuticals SL
![]() 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
Glaxo, Inc. | |
Syntex, Inc. | Miscellaneous |
- Beurs
- Insiders
- Dámaso Molero
- Ervaring